In addition, Tgf‐β1 signaling has been shown to Robo1 expression in mammary epithelial cells [59], suggesting that the Slit2 binding of Robo1 may inhibit the EMT transition of SCLC by suppressing Tgf‐β1 signaling. Here, SLIT2 is linked to small cell lung carcinoma.